DE69942215D1 - Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers - Google Patents

Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers

Info

Publication number
DE69942215D1
DE69942215D1 DE69942215T DE69942215T DE69942215D1 DE 69942215 D1 DE69942215 D1 DE 69942215D1 DE 69942215 T DE69942215 T DE 69942215T DE 69942215 T DE69942215 T DE 69942215T DE 69942215 D1 DE69942215 D1 DE 69942215D1
Authority
DE
Germany
Prior art keywords
antibody
soluble
antigen protein
immunochemical
immunochemical testing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69942215T
Other languages
English (en)
Inventor
Yasuko Ozaki
Yasuo Koishihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69942215D1 publication Critical patent/DE69942215D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69942215T 1998-02-25 1999-02-25 Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers Expired - Lifetime DE69942215D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6061398 1998-02-25

Publications (1)

Publication Number Publication Date
DE69942215D1 true DE69942215D1 (de) 2010-05-12

Family

ID=13147307

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69942215T Expired - Lifetime DE69942215D1 (de) 1998-02-25 1999-02-25 Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers

Country Status (6)

Country Link
EP (2) EP1059533A4 (de)
JP (1) JP3609026B2 (de)
AT (1) ATE462975T1 (de)
AU (1) AU2640399A (de)
DE (1) DE69942215D1 (de)
WO (1) WO1999043703A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077362A1 (fr) * 2000-04-06 2001-10-18 Chugai Seiyaku Kabushiki Kaisha Dosage immunologique d'anticorps anti hm1 . 24
JP4450555B2 (ja) 2000-12-28 2010-04-14 協和発酵キリン株式会社 新規モノクローナル抗体
US7776612B2 (en) 2001-04-13 2010-08-17 Chugai Seiyaku Kabushiki Kaisha Method of quantifying antigen expression
ATE439143T1 (de) * 2002-10-30 2009-08-15 Chugai Pharmaceutical Co Ltd Hm1.24 verwertende krebsvakzine
WO2006008886A1 (ja) 2004-06-11 2006-01-26 Ginkgo Biomedical Research Institute Co., Ltd. インターフェロン産生細胞の活性調節剤
US20080299128A1 (en) 2006-06-20 2008-12-04 Myung Kim Effect of Bst2 on inflammation
CA2620626C (en) 2004-12-20 2011-06-07 Isu Abxis Co., Ltd. Molecules inhibiting intercellular adhesion
US8329186B2 (en) 2004-12-20 2012-12-11 Isu Abxis Co., Ltd Treatment of inflammation using BST2 inhibitor
US7740856B2 (en) 2005-12-20 2010-06-22 Isu Abxis Co., Ltd. Effect of BST2 on inflammation
AU2007299843B2 (en) 2006-09-18 2012-03-08 Xencor, Inc Optimized antibodies that target HM1.24
WO2021081880A1 (zh) * 2019-10-31 2021-05-06 中国科学院深圳先进技术研究院 一种杂交瘤细胞株及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics
UA76934C2 (en) * 1996-10-04 2006-10-16 Chugai Pharmaceutical Co Ltd Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
US6503510B2 (en) * 1997-02-12 2003-01-07 Chugai Seiyaku Kabushiki Kaisha Remedies for lymphocytic tumors
WO1998037913A1 (fr) * 1997-02-28 1998-09-03 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs d'activation de lymphocytes
CN1277632A (zh) * 1997-10-03 2000-12-20 中外制药株式会社 天然人源化抗体

Also Published As

Publication number Publication date
EP1757941B1 (de) 2010-03-31
EP1757941A1 (de) 2007-02-28
JP3609026B2 (ja) 2005-01-12
ATE462975T1 (de) 2010-04-15
AU2640399A (en) 1999-09-15
EP1059533A1 (de) 2000-12-13
WO1999043703A8 (fr) 1999-12-02
EP1059533A4 (de) 2005-02-09
WO1999043703A1 (fr) 1999-09-02

Similar Documents

Publication Publication Date Title
DE69841864D1 (de) Testvorrichtung und Verfahren zum Nachweis von Restanalyten in Proben
WO2002010754A3 (en) Assay apparatus
ATE113722T1 (de) Vorrichtung und verfahren zur bestimmung einer komponente einer probe.
DE59814295D1 (de) Verfahren zur Analytbestimmung unter Verwendung eines universellen Analysenelementes
DE60144551D1 (de) Immunologisch-analytisches Verfahren zur Bestimmung von glykosylierten Proteinen (AGEs)
DE69942215D1 (de) Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers
ATE125572T1 (de) Immunodiagnostisches verfahren zum nachweis und zur bestimmung von euterentzündung.
EP0383313A3 (de) Reagenz für Immuntestverfahren und Kit dieses enhaltend
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE441111T1 (de) Metallchelat-markierte peptide
PT918991E (pt) Metodo de ensaio
ATE403866T1 (de) Verfahren zum nachweis von antikörpern in flüssigen proben
ATE284034T1 (de) Verfahren zum nachweis von protein s
CA2366651A1 (en) A method for detecting megsin protein and use thereof
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
CA2213083A1 (en) Detection of antibody production
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
GR940300091T1 (en) Equipment and test for determining an antigen/antibody in a test sample.
EP0368674A3 (de) Immunoessay und dafür geeignete Testsätze
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
ES2120888A1 (es) Metodo inmunoenzimatico cuantitativo para detectar la adulteracion de leche de oveja con leche de otra especie.
DK1200826T3 (da) Immunoassay og testanordning med integreret reference

Legal Events

Date Code Title Description
8364 No opposition during term of opposition